New York, NY, United States of America

Sven Martin Jacobson

 


Loading Chart...

Title: Sven Martin Jacobson: Innovator in Ischemic Stroke Treatment

Introduction

Sven Martin Jacobson is an inventor based in New York, NY (US). He has made significant contributions to the field of medical treatment, particularly in the area of ischemic stroke. Although he currently holds no granted patents, his work is focused on innovative methods that could potentially improve patient outcomes.

Latest Patent Applications

Sven Martin Jacobson's latest patent applications include the following:

1. **Methods of Treating Ischemic Stroke at Risk for Cerebral or Cerebellar Edema** - This invention relates to the treatment of ischemic stroke at risk of brain swelling using SUR1-TRPM4 channel inhibitors in combination with mechanical thrombectomy. In some embodiments, the methods include treating patients suffering from a large hemispheric infarction. In certain embodiments, patients have a lesion volume of less than 140 cm³ or less than 125 cm³ as measured by MRI DWI or CTP. The patient may have suffered a wake-up stroke. Some embodiments involve treating patients who also undergo decompressive therapy.

2. **Methods of Treating Ischemic Stroke at Risk for Cerebral or Cerebellar Edema** - This disclosure also relates to the treatment of ischemic stroke at risk of brain swelling using SUR1-TRPM4 channel inhibitors. In some embodiments, the methods include treating patients suffering from a large hemispheric infarction. In certain embodiments, patients have a baseline NIHSS of ≤20. In other embodiments, patients have a lesion volume of less than 140 cm³ or less than 125 cm³ as measured by MRI DWI or CTP. The patient may have suffered a wake-up stroke. Some embodiments involve treating patients who also undergo treatment with a thrombolytic agent and/or decompressive therapy.

Conclusion

Sven Martin Jacobson is an innovative inventor whose work focuses on improving treatments for ischemic stroke. His latest patent applications reflect his commitment to advancing medical science and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Loading…